Mutant glucocorticoid receptor binding elements on Interleukin-6 promoter regulate dexamethasone effects
Preprint
Abstract
Glucocorticoid has been widely used as an important modulator for clinical infectious and inflammatory disease. Glucocorticoid receptor (GR) is a transcription factor belonging to the family of nuclear receptors, regulated anti-inflammatory process and the release of pro-inflammatory cytokines. Five putative GR and other transcription factor binding sites on interleukin (IL)-6 promoter were identified and dexamethasone could reduce LPS-induced IL-6 release. Among them, the mutant transcriptional factors NF-κB, AP-1, and Sp1-2 site decreased the basal and effects of lipopolysaccharide (LPS)-induced IL-6 promoter activities in different responses. GR2/3 seemed to be an important role in both basal and inducible promoter activities in LPS-induced inflammation. We concluded that the selective GR2/3 modulators may have agonistic and antagonistic combined effects and activate important signaling pathway during LPS-stimulated inflammatory process.Keywords
All Related Versions
- Published version: BMC Immunology, 22 (1), 1.
This publication has 33 references indexed in Scilit:
- Association of Corticosteroid Treatment With Outcomes in Adult Patients With SepsisJAMA Internal Medicine, 2019
- Low-dose corticosteroids for adult patients with septic shock: a systematic review with meta-analysis and trial sequential analysisIntensive Care Medicine, 2018
- Cytokine storm and sepsis disease pathogenesisSeminars in Immunopathology, 2017
- Glucocorticoid Sensitivity Is Highly Variable in Critically Ill Patients With Septic Shock and Is Associated With Disease Severity*Critical Care Medicine, 2016
- Suppression of Dendritic Cell-Derived IL-12 by Endogenous Glucocorticoids Is Protective in LPS-Induced SepsisPLOS Biology, 2015
- Low-Dose Hydrocortisone Therapy Attenuates Septic Shock in Adult Patients but Does Not Reduce 28-Day MortalityAnesthesia & Analgesia, 2014
- Systemic Steroids in Severe Sepsis and Septic ShockAmerican Journal of Respiratory and Critical Care Medicine, 2012
- The role of the glucocorticoid receptor in inflammation and immunityThe Journal of Steroid Biochemistry and Molecular Biology, 2010
- Molecular mechanisms of glucocorticoid action and selective glucocorticoid receptor agonistsMolecular and Cellular Endocrinology, 2007
- On the mechanism for efficient repression of the interleukin-6 promoter by glucocorticoids: enhancer, TATA box, and RNA start site (Inr motif) occlusion.Molecular and Cellular Biology, 1990